Titlebook: Clinical Trials in Latin America: Where Ethics and Business Clash; Nuria Homedes,Antonio Ugalde Book 2014 Springer International Publishin

積聚

書目名稱Clinical Trials in Latin America: Where Ethics and Business Clash影響因子(影響力)




書目名稱Clinical Trials in Latin America: Where Ethics and Business Clash影響因子(影響力)學(xué)科排名




書目名稱Clinical Trials in Latin America: Where Ethics and Business Clash網(wǎng)絡(luò)公開度




書目名稱Clinical Trials in Latin America: Where Ethics and Business Clash網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Clinical Trials in Latin America: Where Ethics and Business Clash被引頻次




書目名稱Clinical Trials in Latin America: Where Ethics and Business Clash被引頻次學(xué)科排名




書目名稱Clinical Trials in Latin America: Where Ethics and Business Clash年度引用




書目名稱Clinical Trials in Latin America: Where Ethics and Business Clash年度引用學(xué)科排名




書目名稱Clinical Trials in Latin America: Where Ethics and Business Clash讀者反饋




書目名稱Clinical Trials in Latin America: Where Ethics and Business Clash讀者反饋學(xué)科排名

無目標

Book 2014 Agency has defined them as priority countries in Latin America. The authors raise questions about the quality of data obtained from the trials and the violation of human rights during their implementation. Their findings are presented in this volume, the first in-depth analysis of clinical trials in the region. ? ? ? ? ?

否認

Nigel Hoschke,Don C. Price,D. Andrew Scott, Brazil, Costa Rica, Mexico and Peru) where about 80 % of all clinical trials in the region take place and the circumstances that have left some clinical research participants insufficiently protected. A very brief summary of the highlights of each chapter is included.

辯論

crease

Book 2014al information and field work in Argentina, Brazil, Costa Rica, Mexico and Peru, the authors discuss the regulatory contexts and the ethical dimensions of human experimentation in the region. More than 80% of all clinical trials in the region take place in these countries, and the European Medicines

tendinitis

tendinitis

Globalization and Clinical Research in Latin America,of the industry while protecting the rights of clinical trial participants. Using regional information, the authors question if the Latin American context guarantees the protection of the human rights of the participants and their communities, and the integrity of scientific inquiry. The consequence

卷發(fā)

The Regulatory Framework and Case Studies from Argentina,ties and informed journalists, this chapter describes cases where researchers failed to obtain informed consent, duplicated patient records, and violated inclusion and exclusion criteria. The studies that have generated controversy were financed by multinational companies and involved treatments for

Hyperlipidemia

粉筆